И его применение при заболеваниях легких
жүктеу/скачать 142,06 Kb. Pdf көрінісі
|
1089-757-1-PB
| Anzueto A., Baughman R., Guntupalli K. K. et al.
Aerosolized surfactant in adults with septicinduced acute respiratory distress syndrome. N. Eng l. J. Med. 1996; 334: 1417—1421. 36. Bonсˆuk=Dayanikli P., Taeusch W. H. Essential and nonessential con stituents of exogenous surfactants. In: Robertson, B. Taeusch, H. W. (eds.) Surfactant therapy for lung disease. Lung biology in health and disease. 84. N. Y.; 1995: Marcel Dekker, Inc. 217—238. 37. G ü nther A., Ruppert C., Schmidt R. et al. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir. Res. 2001; 2 (6): 353—364. 38. Sanders R. L. The composition of pulmonary surfactant. In: Farrell P. M. (ed.) Lung development: вiological and сlinical рerspectives. N. Y.: Academic Press; 1982. 1. 193—210. 39. Possmayer F. A proposed nomenclature for pulmonary surfactantasso ciated proteins. Am. Rev. Respir. Dis. 1988; 138: 990—998. 40. Persson A., Chang D., Rust D. et al. Purification and biochemical char acterization of CP4 (SPD), a collagenous surfactantassociated pro tein. Biochemistry 1989; 28: 6361—6367. 41. Weaver T. E., Whitsett J. A. Function and regulation of expression of pulmonary surfactantassociated proteins. Biochem. J. 1991; 273: 249—264. 42. Goerke J., Clements J. A. Alveolar surface tension and lung surfactant. In: Handbook of рhysiology. The Respiratory system. Mechanics of вreath ing. 3 Am. Phisiol. Soc. Bethesda; 1986. Sect. 3. P I. 247—263. 43. Schurch S., Bachofen H. Biophysical aspects in the design of a therapeu tic surfactant. In: Rodertson B., Taeush H. W., (eds.) Surfactant thera py for lung disease. Lung biology in health and disease. 84. N. Y.: Marcel Dekker Inc; 1995. 3—26. 44. Horie T., Hildebrandt J. Dynamic compliance, limit cycles and static equilibria of excised cat lung. J. Appl. Physiol. 1971; 31: 423—428. 45. Mead J., Collier C. Relation of volume history of lungs to respiratory mechanics in anesthetized dogs. J. Appl. Physiol. 1959; 14: 669—675. 46. Rosenberg O., Seiliev A., Zhuikov. Lung Surfactant: Correlation beween biophysial charactrisic, composition, and therapeutic effiacy. In: Gregory Gregoriadis, (ed.) Liposome тechnology. Taylor and Francis; 2006. 3ed, 3, сh. 17. 317—345. 47. Bachofen H. et al. Relations among alveolar surface tension, surface area, volume and recoil pressure. J. Appl. Physiol. 1987; 62: 18781891. 48. Sch ü rch S., Goerke J., Clements J. A. Direct determination of volume and timedependence of alveolar surface tension in excised lungs. Proc. Natl. Acad. Sci. USА 1978; 75: 3417—3420. 49. Bachofen H. et al. Experimental hydrostatic pulmonary edema in rabbit lungs. Morphology. Am. Rev. Respir. Dis. 1993; 147: 989—996. 50. Bachofen H., Sch ü rch, S., Weibel I. R. Experimental hydrostatic pul monary edema in rabbit lungs. Barrier lesions. Am. Rev. Respir. Dis. 1993; 147: 997—1006. 51. LaForce F. M., Kelley W. J., Huber J. L. Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material, Am. Rev. Respir. Dis. 1973; 108: 783—789. 52. Wollmer P., Jonson B., Lachmann B. Evaluation of lung permeability. In: Robertson B., Taeusch, H. W., (eds.) Surfactant therapy for lung dis ease. Lung biology in health and disease. N. Y.: Marcel Dekker, Inc.; 1995; 84. 199—215. 53. жүктеу/скачать 142,06 Kb. Достарыңызбен бөлісу:
|